Picard Medical (PMI) Stock: Buy, Sell, or Hold?
PMI - Picard Medical, Inc.
$9.68
0.31 (3.31%)
▲
5d:
+124.07%
30d:
+119.5%
90d:
+5820.49%
WAIT
LOW Confidence
Analysis Updated: Oct 8, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When PMI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: PMI is 43.6% above its trading range ($6.74). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: PMI is 43.6% above its trading range ($6.74). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: PMI is currently trading at $9.68, which is considered extended relative to its 30-day fair value range of $3.96 to $6.74.
Technical Outlook: Technically, PMI is in a strong uptrend. Immediate support is located at $3.85, while resistance sits at $10.19. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: PMI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PMI is in a strong uptrend. Immediate support is located at $3.85, while resistance sits at $10.19. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: PMI scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.96 -
$6.74
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
11.8%
All Signals
- BEARISH: Price significantly overextended (+43.6% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.96 -
$6.74
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.85
Resistance Level
$10.19
Current Trend
Strong Uptrend
Technical data as of
Oct 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.15
Revenue Growth (YoY)
38.6%
Share & Embed Analysis
Last updated: October 08, 2026 9:03 PM ET
Data refreshes hourly during market hours. Next update: 10:03 PM
Data refreshes hourly during market hours. Next update: 10:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMI showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Michael Patrick O'Shea
BUY
4463 shares
2026-04-24
Piers Godfrey Harrison
BUY
4463 shares
2026-04-24
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$61 | 49 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$121 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
28 analysts |
$95 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$101 | 52 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
28 analysts |
$368 | 52 HOLD |